The “CURE FL (Curative Research to Eliminate Follicular Lymphoma) Awards” and “Research United to CURE FL Awards” drive innovation in immunotherapy to revolutionize FL treatment. By focusing on high-impact studies this program supports a clear path to clinical trials and the hope of clear benefit and impact on FL patients. By fostering collaboration among leading scientists around the world, we unlock new treatment possibilities and push the boundaries of what’s possible in FL research.
This initiative advances cutting-edge technologies and techniques to identify and understand biomarkers related to FL. By tackling the biggest challenges in biomarker research, we aim to enhance patient stratification and enable more precise, personalized therapy options. Working alongside leading international experts, we are shaping a strategic roadmap to identify the most promising biomarkers and translate research into real-world clinical impact.
PETReA Plus is a transformative project poised to revolutionize FL management. It aims to develop better treatments that cure FL patients and avoid unnecessary toxic therapies. PETReA Plus is the only study in the world that is prospectively collecting outcomes of initial management from all people with newly diagnosed FL. Through this study, the research team will address gaps in our knowledge crucial for improving cure rates in FL and informing next-generation treatments.
We’d love to hear from you if you’re interested in learning more about the FLF and our initiatives. We welcome your feedback, support, and collaboration in any way you can.
If you want to find out more about the FLF and any of our research programs, please contact us at info@theflf.org.
